NCT03928496View on ClinicalTrials.gov

Abobotulinumtoxina Efficacy in Post-Traumatic Headache

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2013

Primary Completion Date

February 2, 2017

Study Completion Date

February 2, 2017

Conditions
Post-Traumatic Headache
Interventions
DRUG

AbobotulinumtoxinA

Subjects were injected with 0.1 ml (12.5 units of Abobotulinumtoxina) into 31 distinct muscle locations in the head and neck

DRUG

Normal saline

Subjects were injected with 0.1 ml of preservative free normal saline into 31 distinct muscle locations in the head and neck

Trial Locations (1)

90073

VA Greater Los Angeles Healthcare System, Los Angeles

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

VA Greater Los Angeles Healthcare System

FED